Laparoscopic gastric bypass in patients on thyroid replacement therapy for subnormal thyroid function - prevalence and short-term outcome.
BACKGROUND
Hypothyroidism is associated with increased body weight. Weight gain may occur despite normal levels of serum thyroid stimulating hormone (TSH) and thyroxine (T4) achieved by replacement therapy. We evaluated the prevalence of patients on thyroid replacement for subnormal thyroid function who were operated on for morbid obesity and monitored their postoperative weight loss pattern.


METHODS
Data was identified from a prospectively accrued database of patients undergoing laparoscopic Roux-en-Y gastric bypass (LRYGBP) or laparoscopic adjustable gastric banding (LAGB) for morbid obesity from February 2000 to November 2001. All patients with subnormal thyroid function, diagnosed by past thyroid function tests and treated by an endocrinologist, who were on thyroid replacement therapy, were identified; 5 of these were matched for age, gender, preoperative body mass index (BMI) and surgical procedure (LRYGBP) to 5 non-hypothyroid patients. Weight loss at 3 and 9 months after surgery was compared between the 2 groups.


RESULTS
192 patients underwent LRYGBP (n=155) or LAGB (n=37). Of the 21 patients (10.9%) on thyroid replacement identified, 14 were primary, 4 were postablative, and 3 were post-surgical; 17 underwent LRYGBP. All patients had normal preoperative serum levels of TSH and T4. Comparison of the 2 matched groups of patients revealed no difference in weight loss at 3 and 9 months after surgery (P=1.0).


CONCLUSIONS
The prevalence of euthyroid patients on thyroid replacement for subnormal thyroid function who undergo surgical intervention for morbid obesity is high. Short-term weight loss in these patients is comparable to normal thyroid patients. Longer follow-up may be necessary to demonstrate the weight loss pattern in this group.
The Bariatric Institute, Cleveland Clinic Florida, Weston, FL 33331, USA. szomsts@ccf.org
Samuel
S
Szomstein
Shmuel
S
Avital
Oscar
O
Brasesco
Amir
A
Mehran
Jose M
JM
Cabral
Raul
R
Rosenthal
D005260:Female; D015390:Gastric Bypass / Q000379:methods*; D006801:Humans; D007037:Hypothyroidism / Q000150:complications* / Q000188:drug therapy; D010535:Laparoscopy; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications* / Q000601:surgery; D017063:Outcome Assessment, Health Care; D011446:Prospective Studies; D013960:Thyroid Function Tests; D013974:Thyroxine / Q000627:therapeutic use; D015431:Weight Loss
D013974:Thyroxine